About ProNoxis
ProNoxis develops, produces and markets novel treatments for autoimmune disorders where modification of NADPH oxidase (NOX2) activity is one key for diseases like rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease (IBD).
Facts about ProNoxis
Facts about ProNoxis
- Focus : Manufacturer
- Industry : Pharma
